Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
66.21+1.67 (+2.59%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close66.65
Open66.45
Bid62.50 x 800
Ask66.75 x 1200
Day's Range66.32 - 67.04
52 Week Range53.63 - 71.70
Volume3,860,427
Avg. Volume7,299,901
Market Cap207.039B
Beta (5Y Monthly)0.17
PE Ratio (TTM)122.27
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.44 (2.34%)
Ex-Dividend DateFeb 24, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AZN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Astrazeneca PLC
    Analyst Report: AstraZeneca PLCA merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
    Rating
    Fair Value
    Economic Moat
    24 days agoMorningstar
View more
Advertisement
Advertisement